Unveiling Biological Targets with KNIME A Hands-On Workflow Powered by ChEMBL Data

Unveiling #biological #targets with #KNIME? Giovanni Cincilla, Bill Tatsis and Nathan Brown at #Healx developed a #KNIME workflow powered by #ChEMBL data to explore how groups of compounds interact with biological targets—an essential step in #drug #discovery.

📌 #READ → medium.com/low-code-for...

Healx | AI drug discovery | Rare disease treatment At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.

#Healx is a rare disease biotechnology company that uses generative AI for drug discovery. Raised $115M from #Intel Capital, #Global Brain Corporation, #Amadeus Capital Partners, #VU Venture Partners, #Balderton Capital.

How One Startup Is Using AI To Find Cures For 100 Rare Di... It's believed that around 350 million people suffer from ...

How One #Startup Is Using #AI To Find Cures For 100 Rare Diseases By 2025 via @forbes www.forbes.com/sites/nicholasfearn/2018... #HealX #Patients. #FridayMotivation